drugset / Trial / NCT02940366

Effect of High-dose Pitavastatin on Glucose Control in Patients With Metabolic Syndrome

NCT02940366

RandomizedParallel-groupOpen-labelTreatment

Summary

This purpose of this study is to evaluate effect of high-dose Pitavastatin on glucose control in patients with metabolic syndrome.

Timeline

Start
2016-12-01
Primary completion
2019-11-30
Completion
2019-11-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 20 mg Oral
Subject Pitavastatin Small molecule 4 mg

Indications